(Q46712804)

English

Increased vascular selectivity and prolonged pharmacological efficacy of the L-type Ca2+ channel antagonist lercanidipine in human cardiovascular tissue

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Increased vascular selectivity and prolonged pharmacological efficacy of the L-type Ca2+ channel antagonist lercanidipine in human cardiovascular tissue (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

author name string

Klara Brixius

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Thomas Gross

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Paschalios Tossios

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Hans-Joachim Geissler

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Uwe Mehlhorn

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Robert H G Schwinger

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Khosro Hekmat

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

32

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

708-713

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

High affinity specific [3H] (+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Unique pharmacologic properties of amlodipine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2005.04265.X

21 January 2018

Identifiers

10.1111/J.1440-1681.2005.04265.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

release_sgvpe5qmhrhrbeeayr5c2ikidy

1 reference

https://api.fatcat.wiki/v0/release/sgvpe5qmhrhrbeeayr5c2ikidy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16173926

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46712804&oldid=2127737363"